Biobank Automation Systems Market Report 2026
Biobank Automation Systems Market Report 2026
Global Outlook – By Product Type (Automated Storage Systems, Automated Sample Preparation Systems, Automated Liquid Handling Systems, Other Product Types), By Application (Drug Discovery, Regenerative Medicine, Biobanking, Other Applications), By End-User (Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Hospitals, Other End-Users) – Market Size, Trends, Strategies, and Forecast to 2035
Biobank Automation Systems Market Overview
• Biobank Automation Systems market size has reached to $2.03 billion in 2025 • Expected to grow to $3.19 billion in 2030 at a compound annual growth rate (CAGR) of 9.4% • Growth Driver: The Rising Prevalence Of Chronic Diseases Is Fueling The Growth Of The Market Due To Growing Demand For Large Scale, Automated Biospecimen Management. • Market Trend: Innovation In Eco-Friendly Automated Biobanking Solutions • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.
What Is Covered Under Biobank Automation Systems Market?
Biobank automation systems refer to advanced automated technologies, robotics, and digital solutions designed to streamline the collection, processing, tracking, storage, and retrieval of biological samples with high accuracy, efficiency, and security. These systems reduce manual handling, minimize errors, enhance sample traceability, and support large-scale biorepository operations through integrated software, automated storage, and high-throughput workflows. The main product types that comprise biobank automation systems are automated storage systems, automated sample preparation systems, automated liquid handling systems, and others. Automated storage systems refer to highly engineered, temperature-controlled robotic platforms designed to store, preserve, track, and retrieve biological samples with precision and minimal manual contact, ensuring consistent sample integrity across large collections. These systems are used across key applications such as drug discovery, regenerative medicine, biobanking, and others and are used by pharmaceutical and biotechnology companies, academic and research institutes, hospitals, and others.
What Is The Biobank Automation Systems Market Size and Share 2026?
The biobank automation systems market size has grown strongly in recent years. It will grow from $2.03 billion in 2025 to $2.22 billion in 2026 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to growth in biomedical research, increasing biobank sample volumes, need for error reduction, expansion of genomics studies, laboratory automation adoption.What Is The Biobank Automation Systems Market Growth Forecast?
The biobank automation systems market size is expected to see strong growth in the next few years. It will grow to $3.19 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to precision medicine expansion, ai-driven sample management, global biobank collaborations, regulatory compliance requirements, demand for scalable storage solutions. Major trends in the forecast period include automated sample storage, robotic sample handling, high-throughput biobanking, digital sample traceability, integrated biobank software systems.Global Biobank Automation Systems Market Segmentation
1) By Product Type: Automated Storage Systems, Automated Sample Preparation Systems, Automated Liquid Handling Systems, Other Product Types 2) By Application: Drug Discovery, Regenerative Medicine, Biobanking, Other Applications 3) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Hospitals, Other End-Users Subsegments: 1) By Automated Storage Systems: Automated Ultra Low Temperature Freezer Systems, Automated Cryogenic Storage Systems, Automated High Density Biobanking Storage Systems, Automated Room Temperature Sample Storage Systems, Automated Tube And Vial Storage Systems 2) By Automated Sample Preparation Systems: Automated Nucleic Acid Extraction Systems, Automated Cell Preparation Systems, Automated Protein Purification Systems, Automated Histology And Tissue Processing Systems, Automated Sample Aliquoting Systems 3) By Automated Liquid Handling Systems: Automated Pipetting Workstation Systems, Automated Microplate Handling Systems, Automated Reagent Dispensing Systems, Automated Serial Dilution Systems, Automated Microplate Washing Systems 4) By Other Product Types: Automated Tube Decapping And Capping Systems, Barcode Labeling And Scanning Systems, Laboratory Information Management System Integration Modules, Environmental Monitoring And Control Systems, Robotic Laboratory Integration PlatformsWhat Is The Driver Of The Biobank Automation Systems Market?
The rising prevalence of chronic diseases is expected to propel the growth of the biobank automation systems market going forward. Chronic diseases are long-lasting health conditions, such as diabetes, cardiovascular diseases, cancer, and chronic respiratory disorders, that typically progress slowly and persist for months or years, often requiring ongoing medical management. The increasing prevalence of chronic diseases is rising largely due to population aging, as a growing proportion of people are living into older age groups where conditions such as cardiovascular disease, diabetes, and cancer are much more common. Biobank automation systems support the growing burden of chronic diseases by enabling reliable, large-scale storage and rapid retrieval of patient biospecimens for research, biomarker discovery, and development of targeted therapies. For instance, in February 2024, according to the World Health Organization (WHO), a US-based health agency, global cancer incidence is expected to exceed 35 million new cases by 2050, representing a 77% surge over the estimated 20 million new cases recorded in 2022. Therefore, the rising prevalence of chronic diseases is driving the biobank automation systems industry.Key Players In The Global Biobank Automation Systems Market
Major companies operating in the biobank automation systems market are Thermo Fisher Scientific Inc., Azenta Life Sciences, Sartorius AG, Becton Dickinson and Company, Tecan Group Ltd., Hamilton Company, Eppendorf SE, PHC Holdings Corporation, Haier Biomedical Co. Ltd., ASKION GmbH, LiCONiC AG, Micronic Holding B.V., Revvity Inc., Qiagen N.V., Greiner Bio-One International GmbH, BioLife Solutions Inc., LVL Technologies GmbH & Co. KG, RTS Life Science Ltd., Brooks Automation Inc., SP ScientificGlobal Biobank Automation Systems Market Trends and Insights
Major companies operating in the biobank automation systems market are focusing on advanced innovations such as eco-friendly cooling systems to enhance energy efficiency, reduce carbon footprint, and streamline large-scale sample storage operations. Eco-friendly cooling systems refer to advanced refrigeration technologies that use natural air or non-ozone-depleting refrigerants to minimize energy consumption, reduce environmental impact, and support sustainable ultracold storage operations. For instance, in February 2024, Azenta, Inc., a US-based life sciences company, launched the BioArc Ultra, a breakthrough automated solution for high-density and eco-friendly ultracold sample management. BioArc Ultra enables automated, high-density ultracold sample storage and retrieval, helping biobanks maximize freezer capacity while maintaining consistent sample integrity. It supports more sustainable biobanking operations through energy-efficient design and eco-friendly refrigerants, reducing the environmental footprint of large-scale sample management. The system is intended to streamline complex biorepository workflows, reduce manual handling risks, and provide secure, traceable management of critical biological samples for research and clinical applications.What Are Latest Mergers And Acquisitions In The Biobank Automation Systems Market?
In February 2023, Azenta Inc., a US-based life sciences company specializing in automated sample management and cold-chain solutions, acquired Ziath Ltd for an undisclosed amount. With this acquisition, Azenta Inc. aims to strengthen its end-to-end sample lifecycle solutions by integrating advanced two-dimensional barcode scanning technologies that enhance accuracy, traceability, and high-throughput automation across sample registration, storage, and processing workflows for global life sciences customers. Ziath Ltd is a UK-based company specializing in advanced two-dimensional barcode readers and sample tracking technologies that support laboratory automation and biobank automation systems.Regional Outlook
North America was the largest region in the biobank automation systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainWhat Defines the Biobank Automation Systems Market?
The biobank automation systems market consists of revenues earned by entities by providing services such as system installation and validation, biobank workflow design and optimization, integration with laboratory information management systems (LIMS), preventive maintenance and equipment calibration, and training and technical support for automated biobanking operations. The market value includes the value of related goods sold by the service provider or included within the service offering. The biobank automation systems market also includes sales of automated sample storage systems, robotic liquid-handling platforms, automated tube and plate handling systems, barcode labeling and tracking solutions, and biobank sample management software. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.Biobank Automation Systems Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $2.22 billion |
| Revenue Forecast In 2035 | $3.19 billion |
| Growth Rate | CAGR of 9.7% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product Type, Application, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Thermo Fisher Scientific Inc., Azenta Life Sciences, Sartorius AG, Becton Dickinson and Company, Tecan Group Ltd., Hamilton Company, Eppendorf SE, PHC Holdings Corporation, Haier Biomedical Co. Ltd., ASKION GmbH, LiCONiC AG, Micronic Holding B.V., Revvity Inc., Qiagen N.V., Greiner Bio-One International GmbH, BioLife Solutions Inc., LVL Technologies GmbH & Co. KG, RTS Life Science Ltd., Brooks Automation Inc., SP Scientific |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
Frequently Asked Questions
The Biobank Automation Systems Market Report 2026 market was valued at $2.03 billion in 2025, increased to $2.22 billion in 2026, and is projected to reach $3.19 billion by 2030.
request a sample hereThe expected CAGR for the Biobank Automation Systems Market Report 2026 market during the forecast period 2025–2030 is 9.4%.
request a sample hereMajor growth driver of the market includes: The Rising Prevalence Of Chronic Diseases Is Fueling The Growth Of The Market Due To Growing Demand For Large Scale, Automated Biospecimen Management. in the Biobank Automation Systems Market Report 2026 market. For further insights on this market,
request a sample hereThe biobank automation systems market covered in this report is segmented –
1) By Product Type: Automated Storage Systems, Automated Sample Preparation Systems, Automated Liquid Handling Systems, Other Product Types
2) By Application: Drug Discovery, Regenerative Medicine, Biobanking, Other Applications
3) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Hospitals, Other End-Users Subsegments:
1) By Automated Storage Systems: Automated Ultra Low Temperature Freezer Systems, Automated Cryogenic Storage Systems, Automated High Density Biobanking Storage Systems, Automated Room Temperature Sample Storage Systems, Automated Tube And Vial Storage Systems
2) By Automated Sample Preparation Systems: Automated Nucleic Acid Extraction Systems, Automated Cell Preparation Systems, Automated Protein Purification Systems, Automated Histology And Tissue Processing Systems, Automated Sample Aliquoting Systems
3) By Automated Liquid Handling Systems: Automated Pipetting Workstation Systems, Automated Microplate Handling Systems, Automated Reagent Dispensing Systems, Automated Serial Dilution Systems, Automated Microplate Washing Systems
4) By Other Product Types: Automated Tube Decapping And Capping Systems, Barcode Labeling And Scanning Systems, Laboratory Information Management System Integration Modules, Environmental Monitoring And Control Systems, Robotic Laboratory Integration Platforms
request a sample here1) By Product Type: Automated Storage Systems, Automated Sample Preparation Systems, Automated Liquid Handling Systems, Other Product Types
2) By Application: Drug Discovery, Regenerative Medicine, Biobanking, Other Applications
3) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Hospitals, Other End-Users Subsegments:
1) By Automated Storage Systems: Automated Ultra Low Temperature Freezer Systems, Automated Cryogenic Storage Systems, Automated High Density Biobanking Storage Systems, Automated Room Temperature Sample Storage Systems, Automated Tube And Vial Storage Systems
2) By Automated Sample Preparation Systems: Automated Nucleic Acid Extraction Systems, Automated Cell Preparation Systems, Automated Protein Purification Systems, Automated Histology And Tissue Processing Systems, Automated Sample Aliquoting Systems
3) By Automated Liquid Handling Systems: Automated Pipetting Workstation Systems, Automated Microplate Handling Systems, Automated Reagent Dispensing Systems, Automated Serial Dilution Systems, Automated Microplate Washing Systems
4) By Other Product Types: Automated Tube Decapping And Capping Systems, Barcode Labeling And Scanning Systems, Laboratory Information Management System Integration Modules, Environmental Monitoring And Control Systems, Robotic Laboratory Integration Platforms
Major trend in this market includes: Innovation In Eco-Friendly Automated Biobanking Solutions For further insights on this market,
request a sample hereMajor companies operating in the Biobank Automation Systems Market Report 2026 market are Major companies operating in the biobank automation systems market are Thermo Fisher Scientific Inc., Azenta Life Sciences, Sartorius AG, Becton Dickinson and Company, Tecan Group Ltd., Hamilton Company, Eppendorf SE, PHC Holdings Corporation, Haier Biomedical Co. Ltd., ASKION GmbH, LiCONiC AG, Micronic Holding B.V., Revvity Inc., Qiagen N.V., Greiner Bio-One International GmbH, BioLife Solutions Inc., LVL Technologies GmbH & Co. KG, RTS Life Science Ltd., Brooks Automation Inc., SP Scientific
request a sample hereNorth America was the largest region in the biobank automation systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biobank automation systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
request a sample here